Back to company

ABBLO PHARMA ApS: Financial statements 2025

CVR: 34080534

ABBLO PHARMA ApS (CVR 34080534) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 471,866 and a net result of DKK -152,259 compared with DKK 135,215 the year before. That is a decrease of 44.8% compared with the year before. Equity amounted to DKK -238,088. The company had 1 employee in the financial year.

Gross Profit
471,866 kr.
Profit/Loss
-152,259 kr.
Equity
-238,088 kr.
Total Assets
1,161,191 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-472 t.-152 t.-238 t.1
2024-855 t.135 t.-86 t.1
2023-806 t.107 t.-221 t.1
2022-1.1 mio.301 t.-328 t.1
2021-740 t.285 t.-629 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like ABBLO PHARMA ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2025

ABBLO PHARMA ApS: The 2024 annual report is outMay 2, 2025

ABBLO PHARMA ApS has published its annual report for 2024. Gross profit came to DKK 854,994, and the net result was DKK 135,215.

About ABBLO PHARMA ApS

ABBLO PHARMA ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2011. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Nic Borch-Christensen and Mie Hjerrild Petersen. The company is owned by ABBLO S.à.r.l. The company has 0 employees. In 2025, the company reported a gross profit of DKK 471,866 and a net result of DKK -152,259 compared with DKK 135,215 the year before. Equity amounted to DKK -238,088.